Healthcare Economist

Jason Shafrin, PhD, sheds light on the challenge of quantifying the degree to which novel treatments address unmet need and how this would be reflected in different value frameworks.

Jason Shafrin, PhD, argues that more evidence, tools, and physicians with expertise in treating older patients with cancer are needed in order to provide safe and cost-effective treatments that meet patient priorities.

Jason Shafrin, PhD, provides a description of the tools being created by health economists to quantify additional value components of transformative, curative treatments.

Jason Shafrin, PhD, comments on how EHRs must improve to be able to balance physician quality of life with quality patient care.